Ethics of artificial intelligence in the life sciences industry
This podcast is part of the Life Sciences 2030 initiative that explores ethics of artificial intelligence (AI) in the life sciences industry. Moderated by...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
This podcast is part of the Life Sciences 2030 initiative that explores ethics of artificial intelligence (AI) in the life sciences industry. Moderated by...
Biomarkers: what do we mean? – The term “biomarkers” can be broadly clustered into four categories: molecular, histologic, radiographic and physiological. –...
Annabelle Fowler is a panelist during the session titled “Improving Sustainable Biomedical Innovation.” For more information on this event, click here.
Annabelle Fowler is a panelist on “Navigating Today’s Life Sciences M&A Landscape: Charting the Latest Trends and Challenges in Pharma and Biotech Dealmaking”...
Hannah Armstrong is moderating a panel during a program entitled, “Policy Solutions to Improve Access to Fertility Treatment and Optimize Patient Care” and...
CRA is a proud sponsor of the workshop. It is widely recognized as the leading International Arbitration conference held in the United States. The theme of the...